Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

C3orf16 Inhibitors

Ankyrin repeat and ubiquitin domain-containing 1 (ANKUB1) is a protein encoded by the ANKUB1 gene in humans. This protein is characterized by the presence of two distinct domains: an ankyrin repeat domain and a ubiquitin domain. The ankyrin repeat is a 33-amino acid motif commonly involved in protein-protein interactions, and these repeats are often found in proteins that play roles in various cellular processes including signaling, cell cycle control, and transcriptional regulation. The ubiquitin domain signifies the potential involvement of ANKUB1 in ubiquitination, a post-translational modification process where ubiquitin, a small regulatory protein, is attached to substrate proteins, often targeting them for degradation by the proteasome, altering their cellular location, affecting their activity, or promoting or preventing protein interactions.

The specific functions of ANKUB1 are not as well-characterized as some other proteins, but based on its structural domains, it is likely involved in the regulation of protein turnover and may serve as an adapter or scaffold protein that brings other proteins together to form functional complexes. Its ankyrin repeats suggest that it has the capacity for protein binding, potentially influencing the stability, localization, or activity of its interaction partners.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib inhibits the proteasome, potentially impacting protein degradation processes involving ANKUB1.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

PYR-41 inhibits the ubiquitin-activating enzyme E1, potentially affecting ubiquitination processes related to ANKUB1.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A inhibits histone deacetylases, potentially affecting gene expression, including that of ANKUB1.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

NF-κB signaling can be regulated by ubiquitination; inhibitors might indirectly impact ANKUB1 function.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

HSP90 inhibitors can disrupt protein folding and stability, potentially affecting ANKUB1-associated proteins.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

Inhibiting JAK/STAT signaling might indirectly influence ANKUB1 if it's involved in these pathways.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine inhibits autophagy, which could indirectly affect ANKUB1 if it's involved in autophagic processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibitors of the PI3K/Akt pathway might impact signaling pathways relevant to ANKUB1.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR signaling, which can impact protein synthesis and potentially influence ANKUB1 functions.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Bafilomycin A1 inhibits lysosomal function, which could impact cellular pathways involving ANKUB1.